Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

February 28, 2015

Conditions
Adult AngiosarcomaRecurrent Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaStage IV Adult Soft Tissue Sarcoma
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

BIOLOGICAL

Trebananib

Given IV

Trial Locations (70)

10065

Memorial Sloan-Kettering Cancer Center, New York

19718

Christiana Care Health System-Christiana Hospital, Newark

19958

Beebe Medical Center, Lewes

20010

Washington Hospital Center, Washington D.C.

21921

Union Hospital of Cecil County, Elkton MD

45331

Wayne Hospital, Greenville

45373

Upper Valley Medical Center, Troy

45385

Greene Memorial Hospital, Xenia

45405

Grandview Hospital, Dayton

45406

Good Samaritan Hospital - Dayton, Dayton

45409

Miami Valley Hospital, Dayton

45415

Samaritan North Health Center, Dayton

45420

Dayton CCOP, Dayton

45429

Kettering Medical Center, Kettering

45840

Blanchard Valley Hospital, Findlay

46237

Franciscan Saint Francis Health-Indianapolis, Indianapolis

47374

Reid Hospital and Health Care Services, Richmond

51101

Siouxland Regional Cancer Center, Sioux City

51104

Mercy Medical Center-Sioux City, Sioux City

Saint Luke's Regional Medical Center, Sioux City

52242

University of Iowa/Holden Comprehensive Cancer Center, Iowa City

55905

Mayo Clinic, Rochester

60611

Northwestern University, Chicago

61350

Illinois CancerCare-Ottawa Clinic, Ottawa

Ottawa Regional Hospital and Healthcare Center, Ottawa

61354

Illinois CancerCare-Peru, Peru

Illinois Valley Hospital, Peru

61356

Illinois CancerCare-Princeton, Princeton

Perry Memorial Hospital, Princeton

61362

Illinois CancerCare-Spring Valley, Spring Valley

61401

Illinois CancerCare Galesburg, Galesburg

61443

Illinois CancerCare-Kewanee Clinic, Kewanee

61455

Illinois CancerCare-Macomb, Macomb

Mcdonough District Hospital, Macomb

61462

Holy Family Medical Center, Monmouth

Illinois CancerCare-Monmouth, Monmouth

61520

Graham Hospital Association, Canton

Illinois CancerCare-Canton, Canton

61530

Eureka Hospital, Eureka

Illinois CancerCare-Eureka, Eureka

61554

Illinois CancerCare-Pekin, Pekin

Pekin Cancer Treatment Center, Pekin

61603

Methodist Medical Center of Illinois, Peoria

61614

Proctor Hospital, Peoria

61615

Illinois CancerCare-Peoria, Peoria

Illinois Oncology Research Association CCOP, Peoria

61637

OSF Saint Francis Medical Center, Peoria

61701

Saint Joseph Medical Center, Bloomington

61704

Illinois CancerCare-Bloomington, Bloomington

61761

Bromenn Regional Medical Center, Normal

Community Cancer Center Foundation, Normal

Illinois CancerCare-Community Cancer Center, Normal

61801

Carle Cancer Center, Urbana

62321

Illinois CancerCare-Carthage, Carthage

Memorial Hospital, Carthage

62644

Illinois CancerCare-Havana, Havana

Mason District Hospital, Havana

63110

Washington University School of Medicine, St Louis

96701

Oncare Hawaii Inc-Pali Momi, ‘Aiea

Pali Momi Medical Center, ‘Aiea

96734

Castle Medical Center, Kailua

96766

Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue

96813

Oncare Hawaii Inc-POB II, Honolulu

Queen's Medical Center, Honolulu

Straub Clinic and Hospital, Honolulu

University of Hawaii Cancer Center, Honolulu

96817

Oncare Hawaii Inc-Kuakini, Honolulu

96826

Kapiolani Medical Center for Women and Children, Honolulu

08103

Cooper Hospital University Medical Center, Camden

45005-1066

Atrium Medical Center-Middletown Regional Hospital, Franklin

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01623869 - Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter